{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T04:54:45Z","timestamp":1776315285943,"version":"3.50.1"},"reference-count":238,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Glucolipid metabolic disorders (GLMD) have emerged as a significant global public health issue, posing a significant threat to human health. With changes in modern social structures and an ageing population, the incidence of GLMD is on the rise and is increasingly affecting younger populations. Faecal microbiota transplantation (FMT) directly modifies the gut microbiota to reestablish its equilibrium and metabolites, consequently reinstating gut barrier integrity, mitigating chronic low-grade inflammation, and affecting the onset and progression of GLMD through the regulation of the gut-liver axis. This paper reviews the application of FMT in the treatment of GLMD, emphasizing research outcomes and efficacy assessments in clinical trials and animal studies. As a simple and secure intervention, FMT is anticipated to provide new therapeutic alternatives for GLMD patients in the future with the deepening of relevant research, the screening of specific probiotics and the revelation of functional mechanisms. This paper aims to clarify the potential mechanism of FMT in addressing GLMD, summarise recent research developments in this field, and anticipate the opportunities and challenges of FMT in clinical application.<\/jats:p>","DOI":"10.3389\/fendo.2026.1806638","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T04:21:12Z","timestamp":1776313272000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Faecal microbiota transplantation and glucolipid metabolic disorders: the interventional role of gut microbiota"],"prefix":"10.3389","volume":"17","author":[{"given":"Jiali","family":"Wu","sequence":"first","affiliation":[{"name":"Guangdong Metabolic Diseases Research Centre of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education; Guangdong Traditional Chinese Medicine Key Laboratory for Metabolic Diseases, Guangzhou Higher Education Mega Centre, Institute of Chinese Medicine, Guangdong Pharmaceutical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusheng","family":"Qiu","sequence":"additional","affiliation":[{"name":"Guangdong Metabolic Diseases Research Centre of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education; Guangdong Traditional Chinese Medicine Key Laboratory for Metabolic Diseases, Guangzhou Higher Education Mega Centre, Institute of Chinese Medicine, Guangdong Pharmaceutical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaying","family":"Deng","sequence":"additional","affiliation":[{"name":"Guangdong Metabolic Diseases Research Centre of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education; Guangdong Traditional Chinese Medicine Key Laboratory for Metabolic Diseases, Guangzhou Higher Education Mega Centre, Institute of Chinese Medicine, Guangdong Pharmaceutical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangpeng","family":"Li","sequence":"additional","affiliation":[{"name":"Guangdong Metabolic Diseases Research Centre of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education; Guangdong Traditional Chinese Medicine Key Laboratory for Metabolic Diseases, Guangzhou Higher Education Mega Centre, Institute of Chinese Medicine, Guangdong Pharmaceutical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Jia","sequence":"additional","affiliation":[{"name":"Guangdong Metabolic Diseases Research Centre of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education; Guangdong Traditional Chinese Medicine Key Laboratory for Metabolic Diseases, Guangzhou Higher Education Mega Centre, Institute of Chinese Medicine, Guangdong Pharmaceutical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Cao","sequence":"additional","affiliation":[{"name":"Guangdong Metabolic Diseases Research Centre of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education; Guangdong Traditional Chinese Medicine Key Laboratory for Metabolic Diseases, Guangzhou Higher Education Mega Centre, Institute of Chinese Medicine, Guangdong Pharmaceutical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqing","family":"Tao","sequence":"additional","affiliation":[{"name":"Guangdong Metabolic Diseases Research Centre of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education; Guangdong Traditional Chinese Medicine Key Laboratory for Metabolic Diseases, Guangzhou Higher Education Mega Centre, Institute of Chinese Medicine, Guangdong Pharmaceutical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Guo","sequence":"additional","affiliation":[{"name":"Guangdong Metabolic Diseases Research Centre of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education; Guangdong Traditional Chinese Medicine Key Laboratory for Metabolic Diseases, Guangzhou Higher Education Mega Centre, Institute of Chinese Medicine, Guangdong Pharmaceutical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1673-7202.2021.22.003","article-title":"International clinical practice guideline of Chinese medicine glucolipid metabolic disorders(2021-10-14)","volume":"16","year":"2021","journal-title":"World Chin Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/s42003-024-06727-z","article-title":"Fecal microbiota transplantation accelerates restoration of florfenicol-disturbed intestinal microbiota in a fish model","volume":"7","author":"Han","year":"2024","journal-title":"Commun Biol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319548","article-title":"International consensus conference on stool banking for faecal microbiota transplantation in clinical practice","volume":"68","author":"Cammarota","year":"2019","journal-title":"Gut"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-329948","article-title":"The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease","volume":"72","author":"Lopetuso","year":"2023","journal-title":"Gut"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.595759","article-title":"The role of intestinal bacteria and gut-brain axis in hepatic encephalopathy","volume":"10","author":"Chen","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000241","article-title":"Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD\/NASH, HCC, and beyond","volume":"7","author":"Ohtani","year":"2023","journal-title":"Hepatol Commun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115662","article-title":"The gut-liver-brain axis: from the head to the feet","volume":"24","author":"Giuffr\u00e8","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063452","article-title":"Micronutrients at supplemental levels, tight junctions and epithelial barrier function: a narrative review","volume":"25","author":"DiGuilio","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","article-title":"Mechanisms regulating intestinal barrier integrity and its pathological implications","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp Mol Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052506","article-title":"Tight junctions as a key for pathogens invasion in intestinal epithelial cells","volume":"22","author":"Paradis","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2023.01.004","article-title":"Metabolic-associated fatty liver disease and the gut microbiota","volume":"52","author":"Barber","year":"2023","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2331460","article-title":"Breaking the barriers: the role of gut homeostasis in metabolic-associated steatotic liver disease (MASLD)","volume":"16","author":"Bened\u00e9-Ubieto","year":"2024","journal-title":"Gut Microbes"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00805","article-title":"CCR6 deficiency impairs IgA production and dysregulates antimicrobial peptide production, altering the intestinal flora","volume":"8","author":"Lin","year":"2017","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.07.005","article-title":"Intestinal virome signature associated with severity of nonalcoholic fatty liver disease","volume":"159","author":"Lang","year":"2020","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12070647","article-title":"Farnesoid X receptor, bile acid metabolism, and gut microbiota","volume":"12","author":"Mori","year":"2022","journal-title":"Metabolites"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.aninu.2024.05.001","article-title":"Double-side role of short chain fatty acids on host health via the gut-organ axes","volume":"18","author":"Gao","year":"2024","journal-title":"Anim Nutr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413656","article-title":"Pharmacological mechanisms of bile acids targeting the farnesoid X receptor","volume":"25","author":"Qi","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.571731","article-title":"Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes","volume":"11","author":"Scheithauer","year":"2020","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.12.011","article-title":"Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases","volume":"12","author":"Guan","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.134821","article-title":"Butylparaben induces glycolipid metabolic disorders in mice via disruption of gut microbiota and FXR signaling","volume":"474","author":"Du","year":"2024","journal-title":"J Hazard Mater"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.170428","article-title":"Farnesoid X receptor mediates macrophage-intrinsic responses to suppress colitis-induced colon cancer progression","volume":"9","author":"Dong","year":"2024","journal-title":"JCI Insight"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2384","article-title":"The role of secretory antibodies in infection immunity","volume":"8","author":"Strugnell","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00535-017-1400-8","article-title":"Immunoglobulin a and liver diseases","volume":"53","author":"Inamine","year":"2018","journal-title":"J Gastroenterol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1575770","article-title":"Epithelial barrier hypothesis in the context of nutrition, microbial dysbiosis, and immune dysregulation in metabolic dysfunction-associated steatotic liver","volume":"16","author":"Cebi","year":"2025","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31628","article-title":"Neutral ceramidase mediates nonalcoholic steatohepatitis by regulating monounsaturated fatty acids and gut IgA+ B cells","volume":"73","author":"Gu","year":"2021","journal-title":"Hepatology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/17474124.2019.1569513","article-title":"Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease","volume":"13","author":"Suk","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1039\/c7fo01528c","article-title":"Gut\u2009:\u2009liver\u2009:\u2009brain axis: the microbial challenge in the hepatic encephalopathy","volume":"9","author":"Mancini","year":"2018","journal-title":"Food Funct"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1800897","article-title":"Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening","volume":"12","author":"Hueso","year":"2020","journal-title":"Gut Microbes"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0079-6107(02)00037-8","article-title":"Tight junction proteins","volume":"81","author":"Gonz\u00e1lez-Mariscal","year":"2003","journal-title":"Prog Biophys Mol Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/nu14102069","article-title":"Royal jelly protected against dextran-sulfate-sodium-induced colitis by improving the colonic mucosal barrier and gut microbiota","volume":"14","author":"Guo","year":"2022","journal-title":"Nutrients"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.723480","article-title":"The role of \u03b2-carotene in colonic inflammation and intestinal barrier integrity","volume":"8","author":"Cheng","year":"2021","journal-title":"Front Nutr"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114034","article-title":"Gut microbiota and their metabolites in the immune response of rheumatoid arthritis: therapeutic potential and future directions","volume":"147","author":"Cai","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/gutjnl-2016-311571","article-title":"Gut microbiota produce alcohol and contribute to NAFLD","volume":"65","author":"Zhu","year":"2016","journal-title":"Gut"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/nu14245261","article-title":"The prevalence of small intestinal bacterial overgrowth in patients with non-alcoholic liver diseases: NAFLD, NASH, fibrosis, cirrhosis-a systematic review, meta-analysis and meta-regression","volume":"14","author":"Gudan","year":"2022","journal-title":"Nutrients"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.261","article-title":"Gut bifidobacterium pseudocatenulatum protects against fat deposition by enhancing secondary bile acid biosynthesis","volume":"3","author":"Zha","year":"2024","journal-title":"iMeta"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109609","article-title":"Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease","volume":"121","author":"Xi","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B39","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41577-024-01057-x","article-title":"How bile acids and the microbiota interact to shape host immunity","volume":"24","author":"Lee","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.700995","article-title":"Prenatal maternal stress exacerbates experimental colitis of offspring in adulthood","volume":"12","author":"Sun","year":"2021","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2011.41","article-title":"Secretory IgA\u2019s complex roles in immunity and mucosal homeostasis in the gut","volume":"4","author":"Mantis","year":"2011","journal-title":"Mucosal Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13568-023-01520-3","article-title":"The gut microbiota pathway mechanisms of diabetes","volume":"13","author":"Bajinka","year":"2023","journal-title":"Amb Express"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S334325","article-title":"New insights of anti-hyperglycemic agents and traditional Chinese medicine on gut microbiota in type 2 diabetes","volume":"15","author":"Chen","year":"2021","journal-title":"Drug Des Dev Ther"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201900481","article-title":"Implication of the gut microbiota in metabolic inflammation associated with nutritional disorders and obesity","volume":"65","author":"Rodriguez","year":"2021","journal-title":"Mol Nutr Food Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10051014","article-title":"How gut bacterial dysbiosis can promote candida albicans overgrowth during colonic inflammation","volume":"10","author":"Jawhara","year":"2022","journal-title":"Microorganisms"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13409","article-title":"Human microbiome and metabolic health: an overview of systematic reviews","volume":"23","author":"Michels","year":"2022","journal-title":"Obes Rev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2016.83","article-title":"Metagenome-wide association studies: fine-mining the microbiome","volume":"14","author":"Wang","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01340-6","article-title":"Transplant of faecal microbiota from healthy young mice relieves cognitive defects in late-stage diabetic mice by reducing metabolic disorders and neuroinflammation","volume":"45","author":"Ye","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.01127-22","article-title":"A novel synbiotic alleviates autoimmune hepatitis by modulating the gut microbiota-liver axis and inhibiting the hepatic TLR4\/NF-\u03baB\/NLRP3 signaling pathway","volume":"8","author":"Kang","year":"2023","journal-title":"mSystems"},{"key":"B50","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s00018-024-05424-8","article-title":"Tropomodulin1 exacerbates inflammatory response in macrophages by negatively regulating LPS-induced TLR4 endocytosis","volume":"81","author":"Geng","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00018-024-05221-3","article-title":"Flotillins affect LPS-induced TLR4 signaling by modulating the trafficking and abundance of CD14","volume":"81","author":"Matveichuk","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13724","article-title":"Inflammation-mediated metabolic regulation in adipose tissue","volume":"25","author":"Xu","year":"2024","journal-title":"Obes Rev"},{"key":"B53","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/imr.12567","article-title":"Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease","volume":"279","author":"Pickard","year":"2017","journal-title":"Immunol Rev"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202300373","article-title":"Dityrosine aggravates hepatic insulin resistance in obese mice by altering gut microbiota and the LPS\/TLR4\/NF-\u03baB inflammatory pathway","volume":"67","author":"Ding","year":"2023","journal-title":"Mol Nutr Food Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110467","article-title":"LncRNA MEG3 aggravates adipocyte inflammation and insulin resistance by targeting IGF2BP2 to activate TLR4\/NF-\u03baB signaling pathway","volume":"121","author":"Lu","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111019","article-title":"Behenic acid alleviates inflammation and insulin resistance in gestational diabetes mellitus by regulating TLR4\/NF-\u03baB signaling pathway","volume":"27","author":"Liu","year":"2024","journal-title":"iScience"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3906","article-title":"Inflammatory stimuli promote oxidative stress in pancreatic acinar cells via toll-like receptor 4\/nuclear factor-\u03baB pathway","volume":"42","author":"Pan","year":"2018","journal-title":"Int J Mol Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138341","article-title":"Polysaccharides from lactarius volemus Fr. ameliorate high-fat and high-fructose diet induced metabolic disorders and intestinal barrier dysfunction","volume":"287","author":"Xu","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.135844","article-title":"Cordyceps polysaccharide improves polycystic ovary syndrome by inhibiting gut-derived LPS\/TLR4 pathway to attenuates insulin resistance","volume":"280","author":"Zhang","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1039\/d3fo04681h","article-title":"Xylooligosaccharides ameliorate insulin resistance by increasing Akkermansia muciniphila and improving intestinal barrier dysfunction in gestational diabetes mellitus mice","volume":"15","author":"Yang","year":"2024","journal-title":"Food Funct"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2024.09.017","article-title":"Fibroblast growth factor 21 improves insulin sensitivity by modulating the bile acid-gut microbiota axis in type II diabetic mice","volume":"224","author":"Chen","year":"2024","journal-title":"Free Radical Biol Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.3c02429","article-title":"Dendrobium officinale Polysaccharide alleviates type 2 diabetes mellitus by restoring gut microbiota and repairing intestinal barrier via the LPS\/TLR4\/TRIF\/NF-kB axis","volume":"71","author":"Chen","year":"2023","journal-title":"J Agric Food Chem"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2024.11.014","article-title":"Short-chain fatty acids in fetal development and metabolism","volume":"31","author":"Qin","year":"2025","journal-title":"Trends Mol Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"6158","DOI":"10.1080\/10408398.2024.2436644","article-title":"Effects of polyphenols on gut microbiota and inflammatory markers in individuals with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials","volume":"65","author":"Mao","year":"2024","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202400677","article-title":"Synergistic interplay of diet, gut microbiota, and insulin resistance: unraveling the molecular nexus","volume":"68","author":"Gopal","year":"2024","journal-title":"Mol Nutr Food Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2023.101737","article-title":"A major mechanism for immunomodulation: dietary fibres and acid metabolites","volume":"66","author":"Xie","year":"2023","journal-title":"Semin Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.11.007","article-title":"Dietary fiber and SCFAs in the regulation of mucosal immunity","volume":"151","author":"Tan","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1152\/physrev.00041.2018","article-title":"Free fatty acid receptors in health and disease","volume":"100","author":"Kimura","year":"2020","journal-title":"Physiol Rev"},{"key":"B71","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.mucimm.2024.09.003","article-title":"Dissecting the metabolic signaling pathways by which microbial molecules drive the differentiation of regulatory B cells","volume":"18","author":"Luu","year":"2025","journal-title":"Mucosal Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116791","article-title":"When short-chain fatty acids meet type 2 diabetes mellitus: revealing mechanisms, envisioning therapies","volume":"233","author":"Xie","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1039\/d3fo03412g","article-title":"A critical review on intestinal mucosal barrier protection effects of dietary polysaccharides","volume":"15","author":"Yan","year":"2024","journal-title":"Food Funct"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1529958","article-title":"The gut microbiome, immune modulation, and cognitive decline: insights on the gut-brain axis","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2022.2132377","article-title":"The ameliorative effect of probiotics on diet-induced lipid metabolism disorders: a review","volume":"64","author":"Wang","year":"2024","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/foods12132492","article-title":"Ginsenoside Rh4 improves hepatic lipid metabolism and inflammation in a model of NAFLD by targeting the gut liver axis and modulating the FXR signaling pathway","volume":"12","author":"Yang","year":"2023","journal-title":"Foods"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.135422","article-title":"Effects of chitosan guanidine on blood glucose regulation and gut microbiota in T2DM","volume":"279","author":"Liu","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/nu16020269","article-title":"Nutrition at the intersection between gut microbiota eubiosis and effective management of type 2 diabetes","volume":"16","author":"Hamamah","year":"2024","journal-title":"Nutrients"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-022-00794-0","article-title":"The gut microbiota in obesity and weight management: microbes as friends or foe","volume":"19","author":"Van Hul","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.13344\/j.microbiol.China.200098","article-title":"Characteristics of gut microbiota of obese people and machine learning model","volume":"47","author":"Wu","year":"2020","journal-title":"Microbiol China"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112678","article-title":"The links between gut microbiota and obesity and obesity related diseases","volume":"147","author":"Geng","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B82","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12915-019-0699-4","article-title":"The human gut bacteria christensenellaceae are widespread, heritable, and associated with health","volume":"17","author":"Waters","year":"2019","journal-title":"BMC Biol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0495-2","article-title":"Supplementation with akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study","volume":"25","author":"Depommier","year":"2019","journal-title":"Nat Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0156-z","article-title":"Gut microbial metabolites in obesity, NAFLD and T2DM","volume":"15","author":"Canfora","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.06.013","article-title":"Microbiota-produced succinate improves glucose homeostasis via intestinal gluconeogenesis","volume":"24","author":"De Vadder","year":"2016","journal-title":"Cell Metab"},{"key":"B86","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","article-title":"Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis","volume":"30","author":"Cai","year":"2022","journal-title":"Cell Host Microbe"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i25.3837","article-title":"Gut microbiota in obesity","volume":"27","author":"Liu","year":"2021","journal-title":"World J Gastroenterol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-00427-4","article-title":"Circadian rhythms and the gut microbiota: from the metabolic syndrome to cancer","volume":"16","author":"Bishehsari","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/nu16081105","article-title":"Gut microbiota in patients with prediabetes","volume":"16","author":"Chang","year":"2024","journal-title":"Nutrients"},{"key":"B90","doi-asserted-by":"publisher","first-page":"102590","DOI":"10.1016\/j.ebiom.2019.11.051","article-title":"Role of gut microbiota in type 2 diabetes pathophysiology","volume":"51","author":"Gurung","year":"2020","journal-title":"Ebiomedicine"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154712","article-title":"Role of the gut microbiota in type 2 diabetes and related diseases","volume":"117","author":"Yang","year":"2021","journal-title":"Metab Clin Exp"},{"key":"B92","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5110276","article-title":"Gut microbiota and type 2 diabetes mellitus: association, mechanism, and translational applications","volume":"2021","author":"Zhang","year":"2021","journal-title":"Mediators Inflammation"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031105","article-title":"Gut microbiota and short chain fatty acids: implications in glucose homeostasis","volume":"23","author":"Portincasa","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B95","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cmet.2019.11.001","article-title":"Gut microbiome fermentation determines the efficacy of exercise for diabetes prevention","volume":"31","author":"Liu","year":"2020","journal-title":"Cell Metab"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.797062","article-title":"The intestinal effect of atorvastatin: akkermansia muciniphila and barrier function","volume":"12","author":"Cheng","year":"2021","journal-title":"Front Microbiol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cmet.2020.06.011","article-title":"The gut microbiota in prediabetes and diabetes: a population-based cross-sectional study","volume":"32","author":"Wu","year":"2020","journal-title":"Cell Metab"},{"key":"B98","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41569-021-00541-4","article-title":"Global epidemiology of dyslipidaemias","volume":"18","author":"Pirillo","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012415","article-title":"Coronary artery disease risk and lipidomic profiles are similar in hyperlipidemias with family history and population-ascertained hyperlipidemias","volume":"8","author":"R\u00e4m\u00f6","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B100","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12915-019-0715-8","article-title":"The intestinal microbiota regulates host cholesterol homeostasis","volume":"17","author":"Le Roy","year":"2019","journal-title":"BMC Biol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.chom.2018.03.011","article-title":"Small intestine microbiota regulate host digestive and absorptive adaptive responses to dietary lipids","volume":"23","author":"Martinez-Guryn","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1093\/femsec\/fiy045","article-title":"Evidence of dysbiosis in the intestinal microbial ecosystem of children and adolescents with primary hyperlipidemia and the potential role of regular hazelnut intake","volume":"94","author":"Gargari","year":"2018","journal-title":"FEMS Microbiol Ecol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1039\/c5fo00886g","article-title":"Red wine polyphenols modulate faecal microbiota and reduce markers of the metabolic syndrome in obese patients","volume":"7","author":"Moreno-Indias","year":"2016","journal-title":"Food Funct"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.125725","article-title":"Lysimachia christinae polysaccharide attenuates diet-induced hyperlipidemia via modulating gut microbes-mediated FXR-FGF15 signaling pathway","volume":"248","author":"Zhou","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2024.109834","article-title":"Cyanidin-3-rutinoside from Mori Fructus ameliorates dyslipidemia via modulating gut microbiota and lipid metabolism pathway","volume":"137","author":"Zhong","year":"2025","journal-title":"J Nutr Biochem"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3390\/nu14061277","article-title":"Hydrolyzed bound phenolics from rice bran alleviate hyperlipidemia and improve gut microbiota dysbiosis in high-fat-diet fed mice","volume":"14","author":"Zhao","year":"2022","journal-title":"Nutrients"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010176","article-title":"Diet, gut microbiota and non-alcoholic fatty liver disease: three parts of the same axis","volume":"9","author":"Quesada-V\u00e1zquez","year":"2020","journal-title":"Cells"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/biom12010056","article-title":"Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and perspectives","volume":"12","author":"Vallianou","year":"2021","journal-title":"Biomolecules"},{"key":"B110","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1186\/s12887-024-05268-y","article-title":"Non-alcoholic fatty liver disease and the gut microbiota in adolescents: is there a relationship","volume":"24","author":"Amrousy","year":"2024","journal-title":"BMC Pediatr"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109262","article-title":"Liupao tea extract alleviates diabetes mellitus and modulates gut microbiota in rats induced by streptozotocin and high-fat, high-sugar diet","volume":"118","author":"Ding","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B112","doi-asserted-by":"publisher","first-page":"22385","DOI":"10.1038\/s41598-024-72909-8","article-title":"Altered gut microbial profile accompanied by abnormal short chain fatty acid metabolism exacerbates nonalcoholic fatty liver disease progression","volume":"14","author":"Yang","year":"2024","journal-title":"Sci Rep"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.4c08360","article-title":"Heat-processed diet rich in advanced glycation end products induced the onset and progression of NAFLD via disrupting gut homeostasis and hepatic lipid metabolism","volume":"73","author":"Yu","year":"2025","journal-title":"J Agric Food Chem"},{"key":"B114","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41387-024-00306-1","article-title":"Ginger essential oil prevents NASH progression by blocking the NLRP3 inflammasome and remodeling the gut microbiota-LPS-TLR4 pathway in mice","volume":"14","author":"Panyod","year":"2024","journal-title":"Nutr Diabetes"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123164","article-title":"Association between hepatocyte TM4SF5 expression and gut microbiome dysbiosis during non-alcoholic fatty liver disease development","volume":"358","author":"Pinanga","year":"2024","journal-title":"Life Sci"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113173","article-title":"Gut microbiota metabolite trimethylamine N-oxide promoted NAFLD progression by exacerbating intestinal barrier disruption and intrahepatic cellular imbalance","volume":"142","author":"Nian","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v30.i43.4682","article-title":"Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: new frontiers in metabolic dysfunction-associated steatotic liver disease therapy","volume":"30","author":"Guney-Coskun","year":"2024","journal-title":"World J Gastroenterol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2024.106186","article-title":"Effect of ilex hainanensis merr. on HFD-induced nonalcoholic fatty liver disease and rebalance of gut microbiota and bile acids metabolism in mice","volume":"178","author":"Tian","year":"2024","journal-title":"Fitoterapia"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.151033","article-title":"Administration of Alistipes indistinctus prevented the progression from nonalcoholic fatty liver disease to nonalcoholic steatohepatitis by enhancing the gut barrier and increasing Lactobacillus spp","volume":"741","author":"Xu","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202300845","article-title":"Gubra amylin-NASH diet induced nonalcoholic fatty liver disease associated with histological damage, oxidative stress, immune disorders, gut microbiota, and its metabolic dysbiosis in colon","volume":"68","author":"Zhang","year":"2024","journal-title":"Mol Nutr Food Res"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2024.123022","article-title":"Structural characterization of a \u03b1-d-glucan from ginkgo biloba seeds and its protective effects on non-alcoholic fatty liver disease in mice","volume":"349","author":"Liang","year":"2025","journal-title":"Carbohydr Polym"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3390\/cells12192359","article-title":"Innate immune pathways in atherosclerosis-from signaling to long-term epigenetic reprogramming","volume":"12","author":"Aronova","year":"2023","journal-title":"Cells"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c230012","article-title":"Human gut microbiota in cardiovascular disease","volume":"14","author":"Ronen","year":"2024","journal-title":"Compr Physiol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13091141","article-title":"Activation of GABABR attenuates intestinal inflammation by reducing oxidative stress through modulating the TLR4\/MyD88\/NLRP3 pathway and gut microbiota abundance","volume":"13","author":"Deng","year":"2024","journal-title":"Antioxidants"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20160510","article-title":"Introduction to the human gut microbiota","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem J"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2020.08.007","article-title":"TMAO: how gut microbiota contributes to heart failure","volume":"228","author":"Zhang","year":"2021","journal-title":"Transl Res"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.997056","article-title":"Natural products against inflammation and atherosclerosis: targeting on gut microbiota","volume":"13","author":"Deng","year":"2022","journal-title":"Front Microbiol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3364418","article-title":"The relationship among physical activity, intestinal flora, and cardiovascular disease","volume":"2021","author":"Yan","year":"2021","journal-title":"Cardiovasc Ther"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2502041","article-title":"Gut microbiome and atherosclerosis: a Mendelian randomization study","volume":"25","author":"Li","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227147","article-title":"Coronary artery disease is associated with an altered gut microbiome composition","volume":"15","author":"Toya","year":"2020","journal-title":"PloS One"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-024-10480-3","article-title":"The gut microbiome affects atherosclerosis by regulating reverse cholesterol transport","volume":"17","author":"Jiang","year":"2024","journal-title":"J Cardiovasc Transl Res"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1321395","article-title":"Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder","volume":"15","author":"Luqman","year":"2024","journal-title":"Front Immunol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.128037","article-title":"Gut microbial metabolites: the bridge connecting diet and atherosclerosis, and next-generation targets for dietary interventions","volume":"292","author":"Zhang","year":"2025","journal-title":"Microbiol Res"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106586","article-title":"Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis","volume":"187","author":"Cao","year":"2023","journal-title":"Pharmacol Res"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037104","article-title":"Prospect of research on anti-atherosclerosis effect of main components of traditional chinese medicine yiqi huoxue huatan recipe through gut microbiota: a review","volume":"103","author":"Huang","year":"2024","journal-title":"Med (baltimore)"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121947","article-title":"Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD)","volume":"329","author":"Hemmati","year":"2023","journal-title":"Life Sci"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3390\/nu15051212","article-title":"The role of phytochemicals and gut microbiome in atherosclerosis in preclinical mouse models","volume":"15","author":"Centner","year":"2023","journal-title":"Nutrients"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2345134","article-title":"Recipient microbiome-related features predicting metabolic improvement following faecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase 2 clinical trial","volume":"16","author":"Zhang","year":"2024","journal-title":"Gut Microbes"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110803","article-title":"Fecal microbiota transplantation in obesity metabolism: a meta analysis and systematic review","volume":"202","author":"Zecheng","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.4161\/gmic.23571","article-title":"High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen faecal bacteria","volume":"4","author":"Hamilton","year":"2013","journal-title":"Gut Microbes"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3390\/life13071488","article-title":"Fecal microbiota transplantation for weight and glycemic control of obesity as well as the associated metabolic diseases: meta-analysis and comprehensive assessment","volume":"13","author":"Hu","year":"2023","journal-title":"Life"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-020-00265-z","article-title":"Impact of faecal microbiota transplantation with capsules on the prevention of metabolic syndrome among patients with obesity","volume":"20","author":"Allegretti","year":"2021","journal-title":"Hormones"},{"key":"B144","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/diabetology2020004","article-title":"Diabetes mellitus: insights from epidemiology, biochemistry, risk factors, diagnosis, complications and comprehensive management","volume":"2","author":"Alam","year":"2021","journal-title":"Diabetology"},{"key":"B145","doi-asserted-by":"publisher","first-page":"9388","DOI":"10.1038\/s41598-020-64961-x","article-title":"Autologous faecal transplantation from a lean state potentiates caloric restriction effects on body weight and adiposity in obese mice","volume":"10","author":"P\u00e9rez-Matute","year":"2020","journal-title":"Sci Rep"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127654","article-title":"Fecal microbiota transplantation ameliorates abdominal obesity through inhibiting microbiota-mediated intestinal barrier damage and inflammation in mice","volume":"282","author":"Zhu","year":"2024","journal-title":"Microbiol Res"},{"key":"B147","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1055\/a-1263-0898","article-title":"Metabolic syndrome pathophysiology and predisposing factors","volume":"42","author":"Bovolini","year":"2021","journal-title":"Int J Sports Med"},{"key":"B148","doi-asserted-by":"publisher","first-page":"S1499","DOI":"10.14309\/01.ajg.0001037764.01885.95","article-title":"S2099 efficacy of microbiota-based therapies in the management of obesity: a meta-analysis","volume":"119","author":"Berry","year":"2024","journal-title":"Off J Am Coll Gastroenterol | ACG"},{"key":"B149","doi-asserted-by":"publisher","first-page":"7786","DOI":"10.1038\/s41467-025-62752-4","article-title":"Long-term health outcomes in adolescents with obesity treated with faecal microbiota transplantation: 4-year follow-up","volume":"16","author":"Wilson","year":"2025","journal-title":"Nat Commun"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1439176","article-title":"Safety and efficacy of faecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review","volume":"15","author":"Karimi","year":"2024","journal-title":"Front Immunol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1854640","article-title":"Efficacy and safety of faecal microbiota transplantation for the treatment of diseases other than clostridium difficile infection: a systematic review and meta-analysis","volume":"12","author":"Green","year":"2020","journal-title":"Gut Microbes"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2021.1963232","article-title":"Gut microbiota: a target for intervention in obesity","volume":"15","author":"Sehgal","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3390\/nu11102291","article-title":"Impact of faecal microbiota transplantation on obesity and metabolic syndrome-a systematic review","volume":"11","author":"Zhang","year":"2019","journal-title":"Nutrients"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1111\/1751-7915.13951","article-title":"Faecal microbiota transplantation-mediated jejunal microbiota changes halt high-fat diet-induced obesity in mice via retarding intestinal fat absorption","volume":"15","author":"Zhu","year":"2022","journal-title":"Microb Biotechnol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.2337\/db17-1488","article-title":"The transplantation of \u03c93 PUFA-altered gut microbiota of fat-1 mice to wild-type littermates prevents obesity and associated metabolic disorders","volume":"67","author":"Bidu","year":"2018","journal-title":"Diabetes"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41598-017-01751-y","article-title":"Total faecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci Rep"},{"key":"B157","article-title":"Treating obesity and metabolic syndrome with faecal microbiota transplantation","volume":"89","author":"Marotz","year":"2016","journal-title":"Yale J Biol Med"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003051","article-title":"Fecal microbiota transplantation for the improvement of metabolism in obesity: the FMT-TRIM double-blind placebo-controlled pilot trial","volume":"17","author":"Yu","year":"2020","journal-title":"PloS Med"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.759306","article-title":"Effect of faecal microbiota transplantation on non-alcoholic fatty liver disease: a randomized clinical trial","volume":"12","author":"Xue","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.cgh.2019.07.006","article-title":"Effects of faecal microbiota transplantation with oral capsules in obese patients","volume":"18","author":"Allegretti","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.30415","article-title":"Effects of faecal microbiome transfer in adolescents with obesity: the gut bugs randomized controlled trial","volume":"3","author":"Leong","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01399-2","article-title":"Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial","volume":"27","author":"Mocanu","year":"2021","journal-title":"Nat Med"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218143","article-title":"Effects from diet-induced gut microbiota dysbiosis and obesity can be ameliorated by faecal microbiota transplantation: a multiomics approach","volume":"14","author":"Guirro","year":"2019","journal-title":"PloS One"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1126\/science.1241214","article-title":"Gut microbiota from twins discordant for obesity modulate metabolism in mice","volume":"341","author":"Ridaura","year":"2013","journal-title":"Science"},{"key":"B165","doi-asserted-by":"publisher","first-page":"15625","DOI":"10.1038\/s41598-018-33893-y","article-title":"Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice","volume":"8","author":"Lai","year":"2018","journal-title":"Sci Rep"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154935","article-title":"FTZ polysaccharides ameliorate kidney injury in diabetic mice by regulating gut-kidney axis","volume":"118","author":"Lan","year":"2023","journal-title":"Phytomedicine"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1089991","article-title":"Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: a randomized, controlled, prospective study","volume":"12","author":"Wu","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.820367","article-title":"Prospective study reveals host microbial determinants of clinical response to faecal microbiota transplant therapy in type 2 diabetes patients","volume":"12","author":"Ding","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323617","article-title":"Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial","volume":"71","author":"Ng","year":"2022","journal-title":"Gut"},{"key":"B170","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.cgh.2023.09.001","article-title":"Long-term safety outcomes of faecal microbiota transplantation: real-world data over 8 years from the Hong Kong FMT registry","volume":"22","author":"Yau","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.47226","article-title":"Effectiveness of faecal microbiota transplantation for weight loss in patients with obesity undergoing bariatric surgery: a randomized clinical trial","volume":"5","author":"Lahtinen","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0292132","article-title":"Safety and tolerability of frozen, capsulized autologous faecal microbiota transplantation. A randomized double blinded phase I clinical trial","volume":"18","author":"Stefansson","year":"2023","journal-title":"PloS One"},{"key":"B173","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.1038\/s41467-023-41329-z","article-title":"Phage-microbe dynamics after sterile faecal filtrate transplantation in individuals with metabolic syndrome: a double-blind, randomised, placebo-controlled clinical trial assessing efficacy and safety","volume":"14","author":"Wortelboer","year":"2023","journal-title":"Nat Commun"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/s41598-022-05127-9","article-title":"Health improvements of type 2 diabetic patients through diet and diet plus faecal microbiota transplantation","volume":"12","author":"Su","year":"2022","journal-title":"Sci Rep"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.3390\/nu16203491","article-title":"Microbiota transplantation in individuals with type 2 diabetes and a high degree of insulin resistance","volume":"16","author":"G\u00f3mez-P\u00e9rez","year":"2024","journal-title":"Nutrients"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-019-0330-9","article-title":"Fecal microbiota transplantation improves metabolism and gut microbiome composition in db\/db mice","volume":"41","author":"Zhang","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1080\/13880209.2021.1954667","article-title":"Kazak faecal microbiota transplantation induces short-chain fatty acids that promote glucagon-like peptide-1 secretion by regulating gut microbiota in db\/db mice","volume":"59","author":"Han","year":"2021","journal-title":"Pharm Biol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00455","article-title":"Promising treatment for type 2 diabetes: Fecal microbiota transplantation reverses insulin resistance and impaired islets","volume":"9","author":"Wang","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2022-003282","article-title":"Fecal microbiota transplantation ameliorates type 2 diabetes via metabolic remodeling of the gut microbiota in db\/db mice","volume":"11","author":"Chen","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073842","article-title":"Fecal microbiota transplant in a pre-clinical model of type 2 diabetes mellitus, obesity and diabetic kidney disease","volume":"23","author":"Bastos","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1352555","article-title":"Effects of faecal microbiota transplantation on metabolic health of DBA mice","volume":"15","author":"Ye","year":"2024","journal-title":"Front Microbiol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11092415","article-title":"Washed microbiota transplantation improves patients with overweight by the gut microbiota and sphingolipid metabolism","volume":"11","author":"Wu","year":"2023","journal-title":"Biomedicines"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1044957","article-title":"Washed microbiota transplantation improves patients with metabolic syndrome in south China","volume":"12","author":"Wu","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.3390\/md20070444","article-title":"The ameliorative effect of COST on diet-induced lipid metabolism disorders by regulating intestinal microbiota","volume":"20","author":"You","year":"2022","journal-title":"Mar Drugs"},{"key":"B185","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11892-019-1180-z","article-title":"Fecal microbiota transplantation: a future therapeutic option for obesity\/diabetes","volume":"19","author":"Aron-Wisnewsky","year":"2019","journal-title":"Curr Diabetes Rep"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i23.2546","article-title":"Fecal microbiota transplantation in the metabolic diseases: current status and perspectives","volume":"28","author":"Zheng","year":"2022","journal-title":"World J Gastroenterol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2017.1286006","article-title":"Challenges in faecal donor selection and screening for faecal microbiota transplantation: a review","volume":"8","author":"Woodworth","year":"2017","journal-title":"Gut Microbes"},{"key":"B188","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s40168-023-01709-5","article-title":"Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia","volume":"11","author":"Xu","year":"2023","journal-title":"Microbiome"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/6409385","article-title":"Phytosterols alleviate hyperlipidemia by regulating gut microbiota and cholesterol metabolism in mice","volume":"2023","author":"Lv","year":"2023","journal-title":"Oxid Med Cell Longevity"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.3390\/ph18050661","article-title":"Gut microbiota-targeted intervention of hyperlipidemia using monascus-fermented ginseng","volume":"18","author":"Zhou","year":"2025","journal-title":"Pharmaceuticals"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1688070","article-title":"Restoration of peripheral ILC3s by washed microbiota transplantation improves lipid profiles in hyperlipidemia patients","volume":"16","author":"Wei","year":"2025","journal-title":"Front Immunol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9010199","article-title":"Fecal microbiota transplant from human to mice gives insights into the role of the gut microbiota in non-alcoholic fatty liver disease (NAFLD)","volume":"9","author":"Burz","year":"2021","journal-title":"Microorganisms"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-021-01480-z","article-title":"Mechanistic and physiological approaches of faecal microbiota transplantation in the management of NAFLD","volume":"70","author":"Gupta","year":"2021","journal-title":"Inflammation Res"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.20251\/j.cnki.1003-3734.2025.05.011","article-title":"Tianhuang formula enhancing nonalcoholic fatty liver disease in mice through regulating gut microbiota","volume":"34","author":"Zhizhong","year":"2025","journal-title":"Chin New Drugs J"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2024.106247","article-title":"Fufang Zhenzhu Tiaozhi polysaccharides ameliorates high-fat diet-induced non-alcoholic steatohepatitis and intestinal flora disorders in mice","volume":"117","author":"Lan","year":"2024","journal-title":"J Funct Foods"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.984019","article-title":"Tianhuang formula reduces the oxidative stress response of NAFLD by regulating the gut microbiome in mice","volume":"13","author":"Luo","year":"2022","journal-title":"Front Microbiol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.3390\/nu14132749","article-title":"GOS ameliorates nonalcoholic fatty liver disease induced by high fat and high sugar diet through lipid metabolism and intestinal microbes","volume":"14","author":"Qiu","year":"2022","journal-title":"Nutrients"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000661","article-title":"Allogenic fecal microbiota transplantation in patients with nonalcoholic fatty liver disease improves abnormal small intestinal permeability: a randomized control trial","volume":"115","author":"Craven","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29646","article-title":"Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis","volume":"67","author":"Garc\u00eda\u2010Lezana","year":"2018","journal-title":"Hepatology"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1177\/1756284819869144","article-title":"The recognition and attitudes of postgraduate medical students toward faecal microbiota transplantation: a questionnaire study","volume":"12","author":"Wu","year":"2019","journal-title":"Ther Adv Gastroenterol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.16359","article-title":"Hepatobiliary and pancreatic: multi-donor faecal microbiota transplantation attenuated high-fat diet-induced hepatic steatosis in mice by remodeling the gut microbiota","volume":"38","author":"Shou","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2541035","article-title":"Consecutive faecal microbiota transplantation for metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial","volume":"17","author":"Groenewegen","year":"2025","journal-title":"Gut Microbes"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2223330","article-title":"Faecal microbiota transplantation affects liver DNA methylation in non-alcoholic fatty liver disease: a multi-omics approach","volume":"15","author":"Stols-Gon\u00e7alves","year":"2023","journal-title":"Gut Microbes"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2026.1723128","article-title":"Fecal microbiota transplantation alleviates steatosis and inflammation in high-fat and high-sugar diet-induced fatty liver in mice","volume":"14","author":"Mi","year":"2026","journal-title":"Front Cell Dev Biol"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2023.06.015","article-title":"Fecal microbiota transplantation improves hepatic fibro-inflammation via regulating oxidative stress in experimental NASH","volume":"55","author":"Lee","year":"2023","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155919","article-title":"Yellow tea polysaccharides protect against non-alcoholic fatty liver disease via regulation of gut microbiota and bile acid metabolism in mice","volume":"133","author":"Huang","year":"2024","journal-title":"Phytomedicine"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.5c07003","article-title":"Hydroxytyrosol improves metabolic dysfunction-associated fatty liver disease dependent on the modulation of gut microbiota","volume":"73","author":"Xiao","year":"2025","journal-title":"J Agric Food Chem"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156117","article-title":"Z-ligustilide alleviates atherosclerosis by reconstructing gut microbiota and sustaining gut barrier integrity through activation of cannabinoid receptor 2","volume":"135","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"key":"B209","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.atherosclerosis.2023.03.011","article-title":"Empagliflozin ameliorates atherosclerosis via regulating the intestinal flora","volume":"371","author":"Hao","year":"2023","journal-title":"Atherosclerosis"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1016\/S1875-5364(23)60506-0","article-title":"Paeonol reduces microbial metabolite \u03b1-hydroxyisobutyric acid to alleviate the ROS\/TXNIP\/NLRP3 pathway-mediated endothelial inflammation in atherosclerosis mice","volume":"21","author":"Liu","year":"2023","journal-title":"Chin J Nat Med"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-022-00728-w","article-title":"Fecal microbiota transplantation ameliorates atherosclerosis in mice with C1q\/TNF-related protein 9 genetic deficiency","volume":"54","author":"Kim","year":"2022","journal-title":"Exp Mol Med"},{"key":"B212","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","article-title":"Fecal microbiota transplantation protects rotenone-induced parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis","volume":"9","author":"Zhao","year":"2021","journal-title":"Microbiome"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008342","article-title":"Effect of vegan faecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome","volume":"7","author":"Smits","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B214","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1161\/CIRCRESAHA.118.313234","article-title":"A proinflammatory gut microbiota increases systemic inflammation and accelerates atherosclerosis","volume":"124","author":"Brandsma","year":"2019","journal-title":"Circ Res"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202105021","article-title":"Bicyclol alleviates atherosclerosis by manipulating gut microbiota","volume":"18","author":"Li","year":"2022","journal-title":"Small"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313316","article-title":"Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction","volume":"67","author":"Catry","year":"2018","journal-title":"Gut"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.3390\/nu15030661","article-title":"Safety and effects of lactobacillus paracasei TISTR 2593 supplementation on improving cholesterol metabolism and atherosclerosis-related parameters in subjects with hypercholesterolemia: a randomized, double-blind, placebo-controlled clinical trial","volume":"15","author":"Khongrum","year":"2023","journal-title":"Nutrients"},{"key":"B218","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1186\/s12903-024-05230-5","article-title":"Fecal microbiota transplantation validates the importance of gut microbiota in an ApoE-\/- mouse model of chronic apical periodontitis-induced atherosclerosis","volume":"24","author":"Gan","year":"2024","journal-title":"BMC Oral Health"},{"key":"B219","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41522-024-00585-7","article-title":"EphA2 blockage ALW-II-41\u201327 alleviates atherosclerosis by remodeling gut microbiota to regulate bile acid metabolism","volume":"10","author":"Lu","year":"2024","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0314698","article-title":"Fecal bacteria transplantation replicates aerobic exercise to reshape the gut microbiota in mice to inhibit high-fat diet-induced atherosclerosis","volume":"20","author":"Men","year":"2025","journal-title":"PloS One"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156122","article-title":"Aucubin ameliorates atherosclerosis by modulating tryptophan metabolism and inhibiting endothelial-mesenchymal transitions via gut microbiota regulation","volume":"135","author":"Luo","year":"2024","journal-title":"Phytomed Int J Phytother Phytopharm"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157373","article-title":"Dietary fiber pectin supplement attenuates atherosclerosis through promoting akkermansia-related acetic acid metabolism","volume":"148","author":"Mao","year":"2025","journal-title":"Phytomed Int J Phytother Phytopharm"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-020-00603-6","article-title":"Probiotics supplementation and insulin resistance: a systematic review","volume":"12","author":"Salles","year":"2020","journal-title":"Diabetol Metab Syndr"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00060-22","article-title":"Fecal microbiota transplantation: current challenges and future landscapes","volume":"37","author":"Yadegar","year":"2024","journal-title":"Clin Microbiol Rev"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2018.08.011","article-title":"Fecal microbiota transplantation: review and update","volume":"118","author":"Wang","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1601","article-title":"Donor faecal microbiota transplantation alters gut microbiota and metabolites in obese individuals with steatohepatitis","volume":"4","author":"Witjes","year":"2020","journal-title":"Hepatol Commun"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2017.1290756","article-title":"Dietary fiber and prebiotics and the gastrointestinal microbiota","volume":"8","author":"Holscher","year":"2017","journal-title":"Gut Microbes"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.3390\/foods8030092","article-title":"Prebiotics: definition, types, sources, mechanisms, and clinical applications","volume":"8","author":"Davani-Davari","year":"2019","journal-title":"Foods"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101805","article-title":"Effects of metformin on the gut microbiota: a systematic review","volume":"77","author":"Pavlo Petakh","year":"2023","journal-title":"Mol Metab"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4345","article-title":"Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug","volume":"23","author":"Wu","year":"2017","journal-title":"Nat Med"},{"key":"B231","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s11892-019-1269-4","article-title":"Bariatric surgery in the treatment of type 2 diabetes","volume":"19","author":"Affinati","year":"2019","journal-title":"Curr Diabetes Rep"},{"key":"B232","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00394-021-02619-8","article-title":"Micronutrients deficiences in patients after bariatric surgery","volume":"61","author":"Gasmi","year":"2022","journal-title":"Eur J Nutr"},{"key":"B233","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutres.2020.06.018","article-title":"Fecal microbiota transplantation improves metabolic syndrome parameters: systematic review with meta-analysis based on randomized clinical trials","volume":"83","author":"Proen\u00e7a","year":"2020","journal-title":"Nutr Res"},{"key":"B234","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.cmet.2017.09.008","article-title":"Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition","volume":"26","author":"Kootte","year":"2017","journal-title":"Cell Metab"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14891","article-title":"Effect of faecal microbial transplant via colonoscopy in patients with severe obesity and insulin resistance: a randomized double-blind, placebo-controlled Phase 2 trial","volume":"25","author":"Ghorbani","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.12.025","article-title":"Establishing or exaggerating causality for the gut microbiome: lessons from human microbiota-associated rodents","volume":"180","author":"Walter","year":"2020","journal-title":"Cell"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1941711","article-title":"Investigating causality with faecal microbiota transplantation in rodents: applications, recommendations and pitfalls","volume":"13","author":"Gheorghe","year":"2021","journal-title":"Gut Microbes"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-0473-2","article-title":"Of men in mice: the development and application of a humanized gnotobiotic mouse model for microbiome therapeutics","volume":"52","author":"Park","year":"2020","journal-title":"Exp Mol Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1806638\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T04:21:17Z","timestamp":1776313277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1806638\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":238,"alternative-id":["10.3389\/fendo.2026.1806638"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1806638","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"article-number":"1806638"}}